Börskollen - Aktier, fonder och ekonominyheter
Börskollen
•Placeringstips: Bortom utdelningssäsongen: Säkra månatlig ränteavkastning – 11-15 % årsränta (annons)

Pressmeddelanden från Hofseth BioCare

 Bevaka pressreleaser
StartNyheterPressreleaserRiktkurserInsynshandelBlankningAnalyserBloggarVideosPodcasts
13 feb 08:15
Hofseth BioCare
Hofseth BioCare ASA: FOURTH QUARTER 2025 FINANCIAL REPORT11 feb 17:05
Hofseth BioCare
Notification of major shareholdings15 dec 2025 10:04
Hofseth BioCare
Hofseth BioCare ASA: Cancellation of Subsequent Offering – Update on completion of Private Placement21 nov 2025 10:28
Hofseth BioCare
Hofseth BioCare ASA: PRIMARY INSIDER NOTIFICATION21 nov 2025 10:14
Hofseth BioCare
Hofseth BioCare ASA: RESULTS OF SUBSEQUENT OFFERING20 nov 2025 11:30
Hofseth BioCare
Hofseth BioCare ASA: Extraordinary General Meeting completed20 nov 2025 09:11
Hofseth BioCare
Hofseth BioCare ASA: LAST DAY OF SUBSCRIPTION PERIOD IN SUBSEQUENT OFFERING20 nov 2025 08:58
Hofseth BioCare
Hofseth BioCare ASA: HBC ANNOUNCES STRATEGIC PRODUCT PARTNERSHIP WITH JAMES LAVALLE & METABOLIC ELITE10 nov 2025 08:33
Hofseth BioCare
Hofseth BioCare ASA: Publication of the Prospectus – Start of the Subscription Period for the Subsequent Offering07 nov 2025 08:55
Hofseth BioCare
Hofseth BioCare ASA: Terms of the Subsequent Offering07 nov 2025 08:00
Hofseth BioCare
Hofseth BioCare ASA: THIRD QUARTER 2025 FINANCIAL REPORT30 okt 2025 08:36
Hofseth BioCare
Hofseth BioCare ASA: NOTICE OF EXTRAORDINARY GENERAL MEETING27 okt 2025 10:56
Hofseth BioCare
Hofseth BioCare ASA: Mandatory Notification of Trade27 okt 2025 08:03
Hofseth BioCare
Ex. Subsequent Offering Today27 okt 2025 08:02
Hofseth BioCare
Hofseth BioCare ASA: Key Information Relating to Subsequent Offering27 okt 2025 08:01
Hofseth BioCare
Hofseth BioCare ASA: Disclosures of Large Shareholdings27 okt 2025 08:00
Hofseth BioCare
Hofseth BioCare ASA: Private placement successfully placed24 okt 2025 17:56
Hofseth BioCare
Hofseth Biocare ASA: USD 5 Million Divestment in Aecorbio24 okt 2025 17:48
Hofseth BioCare
Hofseth BioCare ASA: Contemplated Private Placement and Partial Divestment of Shares in Aecorbio17 sep 2025 08:55
Hofseth BioCare
Hofseth Biocare ASA: AECORBIO SECURES A FURTHER $1.5M AT A $30M VALUATION FOR ONGOING FT-002A PEPTIDE DEVELOPMENT IN PROSTATE CANCER09 sep 2025 08:58
Hofseth BioCare
Hofseth Biocare ASA: ProGo, the world’s first consumer health GLP-1 & GIP receptor agonist with muscle mass protection via inhibition of Myostatin and Activin A pathways04 sep 2025 11:36
Hofseth BioCare
Hofseth Biocare ASA: HBC onboards former Head of Nestle Health Science Asia, Oceania, Middle East and Africa Region, Paul Bruhn22 aug 2025 08:00
Hofseth BioCare
Hofseth Biocare ASA: SECOND QUARTER 2025 FINANCIAL REPORT16 jul 2025 08:00
Hofseth BioCare
Hofseth Biocare ASA: HBC’s ProGo® has won Ingredient of the Year for Healthy Aging at the prestigious Nutraingredients USA awards ceremony in Chicago23 maj 2025 14:50
Hofseth BioCare
Hofseth Biocare ASA: Annual General Meeting completed16 maj 2025 08:30
Hofseth BioCare
Hofseth Biocare ASA: FIRST QUARTER 2025 FINANCIAL REPORT05 maj 2025 14:19
Hofseth BioCare
Hofseth Biocare ASA: NESTLÉ GARDEN OF LIFE LAUNCHES HBC OMEGO® FULL SPECTRUM OMEGAS IN THE US05 maj 2025 09:00
Hofseth BioCare
Hofseth Biocare ASA: SUCCESSFUL PLACEMENT OF NEW CHF-DENOMINATED UNSECURED BONDS02 maj 2025 12:42
Hofseth BioCare
Hofseth Biocare ASA: NOTICE OF ANNUAL GENERAL MEETING 202511 apr 2025 13:46
Hofseth BioCare
Hofseth Biocare ASA: HBC ANNUAL REPORT 202410 mar 2025 08:00
Hofseth BioCare
Hofseth Biocare ASA: CONTEMPLATING UNSECURED BOND ISSUANCE21 feb 2025 08:30
Hofseth BioCare
Hofseth Biocare ASA: HBC ACCELERATES IN HUMAN HEALTH AND PET NUTRITION THROUGH A STRATEGIC PARTNERSHIP WITH SYMRISE TO BUILD OUT BERKÅK, TRIPLING THE MANUFACTURING CAPACITY OF THE GROUP20 feb 2025 18:19
Hofseth BioCare
Hofseth Biocare ASA: PRIMARY INSIDER NOTIFICATION14 feb 2025 08:45
Hofseth BioCare
Hofseth Biocare ASA: FOURTH QUARTER & FULL YEAR 2024 FINANCIAL REPORT12 dec 2024 15:07
Hofseth BioCare
Hofseth Biocare ASA: PRIMARY INSIDER NOTIFICATION05 dec 2024 09:00
Hofseth BioCare
Hofseth Biocare ASA: Commences the project for a second hydrolysis plant in Norway to triple capacity08 nov 2024 08:15
Hofseth BioCare
Hofseth Biocare ASA: THIRD QUARTER 2024 FINANCIAL REPORT22 okt 2024 10:56
Hofseth BioCare
Hofseth Biocare ASA: CFO RESIGNATION08 okt 2024 08:45
Hofseth BioCare
Hofseth Biocare ASA: HBC IMMUNOLOGY COMPLETES IN VIVO DRUG LEAD STUDIES FOR PROSTATE CANCER TREATMENT23 aug 2024 08:00
Hofseth BioCare
Hofseth Biocare ASA: SECOND QUARTER AND HALF YEAR 2024 FINANCIAL REPORT14 aug 2024 13:09
Hofseth BioCare
Hofseth Biocare ASA: GROUNDBREAKING STUDY REVEALS HOFSETH BIOCARE’S FULL SPECTRUM OMEGAS OMEGO SUPPORTS COVID-19 RECOVERY02 jul 2024 09:00
Hofseth BioCare
Hofseth Biocare ASA: HBC discovers new drug candidate for asthma and transfers it to HBC Immunology Inc. 11 jun 2024 09:00
Hofseth BioCare
Hofseth Biocare ASA: AGREES CHINA DISTRIBUTION PARTNERSHIP WITH SHANGHAI-BASED LITHY16 maj 2024 08:00
Hofseth BioCare
Hofseth Biocare ASA: FIRST QUARTER 2024 FINANCIAL REPORT10 maj 2024 14:30
Hofseth BioCare
Hofseth Biocare ASA: Annual General Meeting completed19 apr 2024 13:00
Hofseth BioCare
Hofseth Biocare ASA: NOTICE OF ANNUAL GENERAL MEETING 202405 apr 2024 18:08
Hofseth BioCare
Hofseth Biocare ASA: DISCLOSURE OF LARGE SHAREHOLDING21 mar 2024 10:40
Hofseth BioCare
Hofseth Biocare ASA: UPDATED COMPANY PRESENTATION14 mar 2024 12:12
Hofseth BioCare
Hofseth Biocare ASA: CHAIR KRISTIN FJELLBY GRUNG STEPS DOWN09 feb 2024 08:00
Hofseth BioCare
Hofseth Biocare ASA: FOURTH QUARTER 2023 AND FULL YEAR FINANCIAL REPORT06 feb 2024 15:56
Hofseth BioCare
Hofseth Biocare ASA: HBC Immunology Inc successfully completes first animal model of prostate cancer with FT-005 in combination with hormonal (anti-androgen) therapy demonstrating significant anti-tumour activity 09 jan 2024 12:44
Hofseth BioCare
Hofseth Biocare ASA: SHARE CAPITAL INCREASE REGISTERED04 jan 2024 14:02
Hofseth BioCare
Hofseth Biocare ASA: EXTRAORDINARY GENERAL MEETING CONCLUDED15 dec 2023 11:29
Hofseth BioCare
Hofseth Biocare ASA: EGM Notice Correction14 dec 2023 13:28
Hofseth BioCare
Hofseth Biocare ASA: Notice of an extraordinary general meeting13 dec 2023 22:49
Hofseth BioCare
Hofseth Biocare ASA: SIGNIFICANT NEW INVESTMENT OF NOK 144 MILLION FROM HOFSETH INTERNATIONAL INTO HBC27 nov 2023 11:06
Hofseth BioCare
Hofseth Biocare ASA: DISCLOSURE OF LARGE SHAREHOLDING27 nov 2023 10:56
Hofseth BioCare
Hofseth Biocare ASA: MANDATORY NOTIFICATION OF TRADE10 nov 2023 08:00
Hofseth BioCare
Hofseth Biocare ASA: THIRD QUARTER 2023 FINANCIAL REPORT25 aug 2023 08:00
Hofseth BioCare
Hofseth Biocare ASA: SECOND QUARTER 2023 FINANCIAL REPORT17 aug 2023 08:58
Hofseth BioCare
Hofseth Biocare ASA: SUCCESSFULLY COMPLETED SEED ROUND CAPITAL RAISE IN HBC IMMUNOLOGY LLC AT $20M VALUATION FOR THE DEVELOPMENT OF A NEW PROSTATE CANCER CO-THERAPY14 jul 2023 14:33
Hofseth BioCare
Hofseth Biocare ASA: PRIMARY INSIDER NOTIFICATION30 maj 2023 08:40
Hofseth BioCare
Hofseth Biocare ASA: ADVANCING THE TREATMENT OF PROSTATE CANCER WITH PUBLICATION OF FTH1 RESEARCH ABSTRACT AHEAD OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY (ASCO) MEETING15 maj 2023 07:50
Hofseth BioCare
Hofseth Biocare ASA: SPIN-OFF OF PROSTATE CANCER CO-TREATMENT PROJECT12 maj 2023 07:56
Hofseth BioCare
Hofseth BioCare ASA: FIRST QUARTER 2023 FINANCIAL REPORT28 apr 2023 14:09
Hofseth BioCare
Hofseth Biocare ASA: COMPLETED ANNUAL GENERAL MEETING28 apr 2023 11:32
Hofseth BioCare
Hofseth Biocare ASA: DISCLOSURE OF VOTING PROXIES13 apr 2023 23:56
Hofseth BioCare
Hofseth Biocare ASA: NOTICE OF ANNUAL GENERAL MEETING 202331 mar 2023 08:00
Hofseth BioCare
Hofseth Biocare ASA: HBC ANNUAL REPORT 202217 feb 2023 08:00
Hofseth BioCare
Hofseth Biocare ASA: PRIMARY INSIDER NOTIFICATION15 feb 2023 18:12
Hofseth BioCare
Hofseth Biocare ASA: PRIMARY INSIDER NOTIFICATION10 feb 2023 08:00
Hofseth BioCare
Hofseth Biocare ASA: FOURTH QUARTER 2022 & FULL YEAR FINANCIAL REPORT30 dec 2022 10:08
Hofseth BioCare
Hofseth Biocare ASA: MANDATORY NOTIFICATION OF TRADE11 nov 2022 08:00
Hofseth BioCare
Hofseth Biocare ASA: THIRD QUARTER 2022 FINANCIAL REPORT17 okt 2022 09:24
Hofseth BioCare
Hofseth Biocare ASA: STANFORD SCHOOL OF MEDICINE SUCCESSFULLY COMPLETES PRE-CLINICAL TRIAL WORK TESTING PROGO® BIOACTIVE PEPTIDES IN EFFECTIVE GUT HEALTH SUPPORT30 aug 2022 14:25
Hofseth BioCare
Hofseth Biocare ASA: COMPLETED EXTRAORDINARY GENERAL MEETING29 aug 2022 08:44
Hofseth BioCare
Hofseth Biocare ASA: HBC’S PROGO BIOACTIVE PEPTIDES NOW IS A “NEW DIETARY INGREDIENT” (NDI) FOR THE US FDA26 aug 2022 08:00
Hofseth BioCare
Hofseth Biocare ASA: SECOND QUARTER & H1 2022 FINANCIAL REPORT09 aug 2022 19:30
Hofseth BioCare
Hofseth Biocare ASA: NOTICE OF EXTRAORDINARY GENERAL MEETING04 aug 2022 12:09
Hofseth BioCare
Hofseth Biocare ASA: SHARE CAPITAL INCREASE REGISTERED29 jul 2022 08:00
Hofseth BioCare
Hofseth Biocare ASA: JON OLAV ØDEGÅRD APPOINTED NEW CEO OF HBC18 jul 2022 11:12
Hofseth BioCare
Hofseth Biocare ASA: NOTIFIABLE TRANSACTION – REDELIVERY OF SHARES11 jul 2022 16:24
Hofseth BioCare
Hofseth Biocare ASA: SHARE CAPITAL INCREASE REGISTERED03 jul 2022 20:45
Hofseth BioCare
DISCLOSURE OF LARGE SHAREHOLDING – AQUA-SPARK03 jul 2022 20:42
Hofseth BioCare
Hofseth Biocare ASA: NOTIFIABLE TRANSACTIONS IN CONNECTION WITH PRIVATE PLACEMENT03 jul 2022 20:32
Hofseth BioCare
Hofseth Biocare ASA: PRIVATE PLACEMENT SUCCESSFULLY PLACED01 jul 2022 16:53
Hofseth BioCare
Hofseth Biocare ASA: CONTEMPLATED PRIVATE PLACEMENT06 maj 2022 13:34
Hofseth BioCare
Hofseth Biocare ASA: CORRECTION: MANDATORY NOTIFICATION OF TRADE 06 maj 2022 12:46
Hofseth BioCare
Hofseth Biocare ASA: MANDATORY NOTIFICATION OF TRADE06 maj 2022 08:00
Hofseth BioCare
Hofseth Biocare ASA: FIRST QUARTER 2022 FINANCIAL REPORT29 apr 2022 15:24
Hofseth BioCare
Hofseth Biocare ASA: APPROVAL OF NEW SHARE INCENTIVE PROGRAM FOR CONSULTANTS – MANDATORY NOTIFICATION OF TRADE29 apr 2022 15:17
Hofseth BioCare
Hofseth Biocare ASA: COMPLETED ANNUAL GENERAL MEETING08 apr 2022 15:49
Hofseth BioCare
Hofseth Biocare ASA: NOTICE OF ANNUAL GENERAL MEETING 202225 mar 2022 16:48
Hofseth BioCare
Hofseth Biocare ASA: HBC ANNUAL REPORT 202111 mar 2022 08:00
Hofseth BioCare
Hofseth Biocare ASA: HOFSETH BIOCARE AWARDED BEST SUSTAINABLE BIOTECH COMPANY 2022 ACCOLADE 08 feb 2022 08:00
Hofseth BioCare
Hofseth Biocare ASA: HOFSETH BIOCARE SECURES INNOVATION AWARD FOR MEDICAL NUTRITION04 feb 2022 07:59
Hofseth BioCare
Hofseth Biocare ASA: FOURTH QUARTER 2021 FINANCIAL REPORT22 dec 2021 14:34
Hofseth BioCare
Hofseth Biocare ASA: MANDATORY NOTIFICATION OF TRADE03 dec 2021 13:55
Hofseth BioCare
Hofseth Biocare ASA: COMPLETED EXTRAORDINARY GENERAL MEETING02 dec 2021 08:45
Hofseth BioCare
Hofseth Biocare ASA: HBC INGREDIENTS SUCCESSFULLY RECEIVE NEW DIETARY INGREDIENT (NDI) STATUS FROM THE US FDA